BioStock: PHI’s CEO comments on the approved US listing
![](https://phiab.com/wp-content/uploads/2024/08/Biostock-PHI-CEO-comments-on-the-approved-US-listing.jpg)
Phase Holographic Imaging has been approved for a dual US listing in addition to its primary listing on the Swedish Spotlight market. What does this mean for the company’s shareholders, and how might it impact the company’s long-term valuation? BioStock reached out to PHI’s CEO Patrik Eschricht to discuss this and the upcoming redemption of the TO4 warrants that could potentially raise SEK 20.8 million in October.
Read the full interview with Patrik Eschricht on biostock.se.
Further reading
![2024-08-15-Proactive-CEO-interview-OTCQBPHIXF](https://phiab.com/wp-content/uploads/2024/08/2024-08-15-Proactive-CEO-interview-OTCQBPHIXF-320x180.jpg)
OTC Market Center in New York welcomes PHI
Our very own ‘big apple’ news — PHI’s shares (OTCQB:PHIXF) are now also trading on the US-OTCQB Market! Go and see some snapshots and our CEO Patrik speaking on this exciting new chapter.
![Interview-John-More-website](https://phiab.com/wp-content/uploads/2024/07/Interview-John-More-website-320x180.jpg)
Interview with John Moore
Meet John Moore, the proposed new board member for PHI. John’s extensive experience and visionary mindset make him an invaluable addition to our team. Let’s dive into his journey and what made him interested in PHI.
![Biostock-PHI-US-listing-interview](https://phiab.com/wp-content/uploads/2024/07/Biostock-PHI-US-listing-interview-320x180.jpg)
BioStock: PHI aims for US listing
BioStock has talked to PHI’s CEO, Patrik Eschricht, to learn more about what the dual listing on the US OTCQB market means for the company and its plans for the future.
![biostock-phi-grows-its-network-of-collaborations-wheels-in-motion](https://phiab.com/wp-content/uploads/2024/06/biostock-phi-grows-its-network-of-collaborations-wheels-in-motion-320x180.jpg)
BioStock: PHI grows its network of collaborations
BioStock caught up with PHI’s CEO Patrik Eschricht to ask about his outlook for the growing number of academic collaborations and sales partnerships.